Cargando…
Drugs That Mimic Hypoxia Selectively Target EBV-Positive Gastric Cancer Cells
SIMPLE SUMMARY: Epstein-Barr virus (EBV) infects greater than 90% of the world’s population and remains in infected people for their lifetime, mostly in a latent form of infection. In some people, latent EBV infection leads to cancer, including EBV-associated gastric carcinomas. Lytic-induction ther...
Autores principales: | Cordes, Blue-leaf A., Bilger, Andrea, Kraus, Richard J., Ward-Shaw, Ella T., Labott, Madeline R., Lee, Shinhyo, Lambert, Paul F., Mertz, Janet E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046841/ https://www.ncbi.nlm.nih.gov/pubmed/36980731 http://dx.doi.org/10.3390/cancers15061846 |
Ejemplares similares
-
EBV Positive Gastric Carcinomas and Their Clinicopathological Characteristics
por: Ognjenovic, Ljubomir, et al.
Publicado: (2018) -
Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
por: Kraus, Richard J., et al.
Publicado: (2017) -
EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives
por: Sun, Keran, et al.
Publicado: (2020) -
The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023) -
MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020)